Dengue fever is a global mosquito-borne viral infectious
disease
that has, in recent years, rapidly spread to almost all regions of
the world. Lack of vaccination and directed treatment makes detection
at the infection’s early stages extremely important for disease
prevention and clinical care. In this paper, we developed a rapid
and highly sensitive dengue detection tool using a novel platform
of diagnosis, called spin-enhanced lateral flow immunoassay (SELFIA)
with a fluorescent nanodiamond (FND) as a reporter. Taking advantage
of the unique magneto-optical properties of negatively charged nitrogen-vacancy
centers in the FND, the SELFIA platform utilizes alternating electromagnetic
fields to modulate signals from FND’s fluorescence to provide
sensitive and specific results. With sandwich SELFIA, we could efficiently
detect all four dengue non-structural protein (NS1) serotypes (DV1,
DV2, DV3, and DV4). The lowest detection concentration of the dengue
NS1 antigens varied from 0.1 to 1.3 ng/mL, which is among the lowest
limits of detection to date. The FND-based SELFIA technique is up
to 500 and 5000 times more sensitive than carbon black and conventional
gold nanoparticles, respectively. By using different anti-NS1 antibodies,
we could differentiate the NS1 antigen serotypes contained in the
tested samples via three simultaneous assays. Proposed SELFIA allows
for both qualitative and quantitative differentiation between different
NS1 protein serotypes, which will assist in the development of a highly
sensitive and specific detection platform for dengue screening that
has the potential to detect the disease at its early stages, especially
in high-risk and limited-resource areas.